- First and only kidney product that does not deliver protein to the body.* Protein is toxic for people with chronic kidney disease and can worsen the condition.
- Patented in 40 countries including all 38 member countries of the European Patent Organisation, Canada, and Japan. Pending United States.
- Low-risk tool and market disruptor
that delivers benefits to health that
are not achieved with other strategies.
- Extensive non-clinical and clinical assets support safety and effectiveness of the product technology.
- Significant manufacturing partnerships with industry titans provide scale, reach, and infrastructure for global brand longevity.
* In a survey of medications and supplements commonly prescribed and used to help treat chronic kidney disease and support kidney health.
Help make a difference for millions of people in need. Become part of a great success story and join our equity crowdfunding campaign today. Visit wefunder.com/fluidlock
